How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2026 · second_quarter · Q2
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Source: Senate LDA
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2026 · first_quarter · Q1
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2025 · fourth_quarter · Q4
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2025 · third_quarter · Q3
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2025 · second_quarter · Q2
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2025 · first_quarter · Q1
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Rare Disease education and advocacy, IRA and Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2024 · fourth_quarter · Q4
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2024 · third_quarter · Q3
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2024 · second_quarter · Q2
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2024 · first_quarter · Q1
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2023 · fourth_quarter · Q4
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2023 · third_quarter · Q3
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2023 · third_quarter · 3T
Medicare and Medicaid rare disease
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2023 · second_quarter · Q2
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2023 · second_quarter · Q2
Medicare and Medicaid rare disease
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2023 · first_quarter · Q1
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2023 · first_quarter · Q1
Medicare and Medicaid rare disease
Medicare and Medicaid rare diseases
Medicare and Medicaid rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2022 · fourth_quarter · Q4
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2022 · fourth_quarter · Q4
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2022 · third_quarter · Q3
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2022 · third_quarter · Q3
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2022 · second_quarter · Q2
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2022 · second_quarter · Q2
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2022 · first_quarter · Q1
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2022 · first_quarter · Q1
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2021 · fourth_quarter · Q4
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2021 · fourth_quarter · Q4
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2021 · third_quarter · Q3
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2021 · third_quarter · Q3
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2021 · second_quarter · Q2
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2021 · second_quarter · Q2
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2021 · first_quarter · Q1
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2021 · first_quarter · Q1
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2020 · fourth_quarter · Q4
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2020 · fourth_quarter · Q4
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2020 · third_quarter · Q3
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2020 · third_quarter · Q3
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2020 · second_quarter · Q2
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2020 · second_quarter · Q2
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2020 · first_quarter · Q1
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2020 · first_quarter · Q1
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2019 · fourth_quarter · Q4
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2019 · fourth_quarter · Q4
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2019 · third_quarter · Q3
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2019 · third_quarter · Q3
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2019 · second_quarter · Q2
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2019 · second_quarter · Q2
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2019 · first_quarter · Q1
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2019 · first_quarter · Q1
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2018 · fourth_quarter · Q4
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Reimbursement for rare disease patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE ACCESS ACTION PROJECT via COMMONWEALTH POLICY SOLUTIONS
2018 · fourth_quarter · RR
reimbursement for rare disease patient care
reimbursement for rare disease patient care
reimbursement for rare disease patient care
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2018 · fourth_quarter · Q4
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2018 · third_quarter · Q3
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via COMMONWEALTH POLICY SOLUTIONS
2018 · third_quarter · RR
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology
Medical device development for oncology, drug delivery for oncology